Vittoria Biotherapeutics is a biotechnology company headquartered in Philadelphia, Pennsylvania. The company focuses on developing advanced cell therapies with an emphasis on oncology and immunology.
Subscribe to see ViTToria Biotherapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ViTToria Biotherapeutics, Inc. is a company headquartered in Philadelphia, United States. It has raised at least $48.7M across the 3 funding rounds on record. Its most recent funding round raised $25M in November 2024. Xcout tracks 6 named people at ViTToria Biotherapeutics, Inc., including Nicholas A. Siciliano (Chief Executive Officer, Co-Founder & Director).
As of 16 November 2026. Source: Xcout Intel.
At least $48.7M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $25M | 7 named | |
| — | $15M | 7 named | |
| SEC Form D filing | $8.7M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A funding-flow diagram of the 8 named investors across 2 rounds: who backed which round, who led it, and who came back for the next one.
Sign in to see it, or subscribe for the full funding history →
A few of ViTToria Biotherapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
GENEOS Therapeutics, Inc. is a biotechnology company focused on developing exquisitely personalized, EPIC-based cancer immunotherapies. The company is headquartered in Philadelphia, Pennsylvania, United States.
Century Therapeutics is an innovative biotechnology company headquartered in Philadelphia, Pennsylvania. Its mission is to develop allogeneic, iPSC-derived NK and T cell therapies that are designed to be more effective, tolerable, and accessible.
VintaBio is a viral vector development and manufacturing organization headquartered in Philadelphia, Pennsylvania. The company provides reliable production services and manufacturing platforms to support clinical-stage gene therapy developers.
Imvax, Inc. is a clinical-stage biotechnology company headquartered in Philadelphia, Pennsylvania, focused on developing personalized, whole-cell immunotherapies for the treatment of various cancers.
Carisma Therapeutics is a clinical-stage biotechnology company headquartered in Philadelphia, Pennsylvania, focused on discovering and developing engineered macrophage-based immunotherapies.
Code Biotherapeutics, Inc. is a biotechnology company headquartered in the Greater Philadelphia area. The firm focuses on next-generation gene therapies and advanced medicine.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about ViTToria Biotherapeutics, Inc.? Suggest a correction · Work at ViTToria Biotherapeutics, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.